Genmab
GMAB
Genmab (GMAB) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $50.00 from $40.00 | Oct 7, 2026 |
| Truist Securities | Maintained | Buy | $45.00 from $40.00 | Oct 7, 2026 |
| Guggenheim | Maintained | Buy | $58.00 from $54.00 | Oct 7, 2026 |
| Guggenheim | Maintained | Buy | $54.00 from $45.00 | Oct 5, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $40.00 | Sep 14, 2026 |
| Guggenheim | Maintained | Buy | $42.00 from $40.00 | Aug 7, 2026 |
| TD Cowen | Upgraded | Hold → Buy | $43.00 from $32.00 | Jul 22, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $40.00 from $38.00 | Jul 2, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $38.00 | Jun 23, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $38.00 from $40.00 | Apr 30, 2026 |
| Wolfe Research | Initiated Coverage | Outperform | $32.00 | Mar 27, 2026 |
| Wells Fargo | Initiated Coverage | Overweight | $40.00 | Mar 2, 2026 |
| Guggenheim | Maintained | Buy | $40.00 from $45.00 | Feb 23, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $40.00 from $39.00 | Feb 18, 2026 |
| Jefferies | Maintained | Buy | $41.50 | Feb 17, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $34.00 | Feb 16, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $39.00 | Jan 28, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $39.00 from $41.00 | Jan 20, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $41.00 from $40.00 | Nov 10, 2025 |
| Truist Securities | Maintained | Buy | $48.00 from $49.00 | Nov 7, 2025 |
Frequently asked questions
What is the latest analyst rating on GMAB?
On Oct 7, 2026, HC Wainwright & Co. maintained Genmab at Buy with a price target of $50.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.